Optum: RWD Will Become Key Component on Pharma’s Corporate Strategy

February 12, 2020

A recent article by Optum on its Amplified blog takes a deep dive into how real-world data (RWD) will “become the bedrock that informs pharma corporate strategy.”

Pharmaceutical companies, the post states, must have a “data driven, long-term vision” of how diseases and treatment options might evolve over time in order to make well-informed investment decisions.

“The goal of pharmaceutical long-term strategic planning is to help the organization align talent and investments across the organization far enough in advance so that new therapies can be discovered, developed and brought to market faster than those of competitors,” the article states.

To read the full article, click here.

Share This Story!